Inherited neurodegenerative diseases and transgenic models

Brain Pathology

Volumn 6, Issue 4, 1996, Pages 467-480

  Price, Donald L ^a   Becher, Mark W ^a   Wong, Philip C ^a   Borchelt, David R ^a   Lee, Michael K ^a   Sisodia, Sangram S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CONFERENCE PAPER; GENE MUTATION; HUMAN; NONHUMAN; TRANSGENIC ANIMAL;

EID: 0029910953     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.1996.tb00876.x     Document Type: Conference Paper

References (220)

1. Albin RL (1995) Selective neurodegeneration in Huntington's disease. Ann Neurol 38:835-836
2. Alzheimer's Disease Collaborative Group (1995) The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Nature Genetics 11:219-222
3. Anderson AJ, Su JH, Cotman CW (1996) DNA damage and apoptosis in Alzheimer's disease. colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay J Neurosci 16:1710-1719
4. Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW (1991) The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex 1.103-116
5. Bading H, Segal MM, Sucher NJ, Dudek H, Lipton SA, Greenberg ME (1995) N-methyl-D-aspartate receptors are critical for mediating the effects of glutamate on intracellular calcium concentration and immediate early gene expression in cultured hippocampal neurons. Neuroscience 64:653-664
6. Beal MF, Mazurek MF, Tran VT, Chattha G, Bird ED, Martin JB (1985) Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's disease. Science 229:289-291
7. Beckman JS, Carson M, Smith CD, Koppenol WH (1993) ALS, SOD and peroxynitrite. Nature 364.584
8. Bingham PM, Scott MO, Wang S, McPhaul MJ, Wilson EM, Garbern JY, Merry DE, Fischbeck KH (1995) Stability of an expanded trinucleotide repeat in the androgen receptor gene in transgenic mice. Nature Genetics 9:191-196
9. Bird TD (1994) Clinical genetics of familial Alzheimer disease In. Alzheimer Disease, Terry RD, Katzman R, Bick KL (eds.), pp 65-74, Raven Press: New York,
10. Bondareff W, Mountjoy CQ, Roth M (1982) Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia. Neurology 32:164-168
11. Bondi MW, Salmon DP, Butters NM (1994) Neuropsychological features of memory disorders in Alzheimer disease. In: Alzheimer Disease, Terry RD, Katzman R, Bick KL (eds.), pp 41-63, Raven Press: New York.
12. Borchelt DR, Lee MK, Slunt HH, Guarnieri M, Xu Z-S, Wong PC, Brown RH, Jr., Price DL, Sisodia SS, Cleveland DW (1994) Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc Natl Acad Sci USA 91:8292-8296
13. Borchelt DR, Guarnieri M, Wong PC, Lee MK, Slunt HS, Xu Z, Sisodia SS, Price DL, Cleveland DW (1995) Superoxide dismutase 1 subunits with mutations linked to familial amyotrophic lateral sclerosis do not affect wild-type subunit function J Biol Chem 270:3234-3238
14. Braak H, Braak E, Bohl J, Reintjes R (1996a) Age, neurofibrillary changes, Aβ-amyloid and the onset of Alzheimer's disease Neurosci Lett 210.87-90
15. Braak H, Braak E, Yilmazer D, de Vos RAI, Jansen ENH, Bohl J (1996b) Pattern of brain destruction in Parkinson's and Alzheimer's diseases J Neural Transm 103:455-490
16. Braak H, Braak E (1991a) Neuropathological stageing of Alzheimer-related changes Acta Neuropathol 82:239-259
17. Braak H, Braak E (1991b) Alzheimer's disease affects limbic nuclei of the thalamus Acta Neuropathol 81:261-268
18. Braak H, Braak E (1994) Pathology of Alzheimer's disease. In: Neurodegenerative Diseases, Calne DB (ed.), pp 585-613, W.B. Saunders: Philadelphia.
19. Bradley WG, Good P, Rasool CG, Adelman LS (1983) Morphometric and biochemical studies of peripheral nerves in amyotrophic lateral sclerosis. Ann Neurol 14:267-277
20. Brion J-P (1990) Molecular pathology of Alzheimer amyloid and neurofibrillary tangles. Semin Neurosci 2:89-100
21. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, Hunter K, Stanton VP, Thinon J-P, Hudson T, Sohn R, Zemelman B, Snell RG, Rundle SA, Crow S, Davies J, Shelbourne P, Buxton J, Jones C, Juvonen V, Johnson K, Harper PS, Shaw DJ, Housman DE (1992) Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68:799-808
22. Brooks BP, Fischbeck KH (1995) Spinal and bulbar muscular atrophy: a trinucleotide-repeat expansion neurodegenerative disease Trends Neurosci 18:459-461
23. Brusa R, Zimmermann F, Koh D-S, Feldmeyer D, Gass P, Seeburg PH, Sprengel R (1995) Early-onset epilepsy and postnatal lethality associated with an editing-deficient GluR-B allele in mice. Science 270:1677-1680
24. Burke JR, Enghild JJ, Martin ME, Jou Y-S, Myers RM, Roses AD, Vance JM, Strittmatter WJ (1996) Huntington and DRPLA proteins selectively interact with the enzyme GAPDH. Nature Med 2:347-350
25. Burright EN, Clark HB, Servadio A, Matilla T, Feddersen RM, Yunis WS, Duvick LA, Zoghbi HY, Orr HT (1995) SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell 82:937-948
26. Campuzano V, Montermini L, Moltò MD, Pianese L, Cossée M, Cavalcanti F, Monros E, Rodius F, Duclos F, Monticelli A, Zara F, Cañizares J, Koutnikova H, Bidichandani SI, Gellera C, Brice A, Trouillas P, De Michele G, Filla A, De Frutos R, Palau F, Patel PI, Di Donate S, Mandel J-L, Cocozza S, Koenig M, Pandolfo M (1996) Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion Science 271:1423-1427
27. Capecchi MR (1989) Altering the genome by homologous recombination. Science 244:1288-1299
28. Carpenter S (1968) Proximal axonal enlargement in motor neuron disease. Neurology 18:841-851
29. Caskey CT, Pizzuti A, Fu Y-H, Fenwick RG, Jr., Nelson DL (1992) Triplet repeat mutations in human disease. Science 256:784-789
30. Chartier-Harlin M-C, Crawford F, Houlden H, Warren A, Hughes D, Fidani L, Goate A, Rossor M, Roques P, Hardy J, Mullan M (1991) Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature 353:844-846
31. Chartier-Harlin M-C, Parfitt M, Legrain S, et al. (1994) Apolipoprotein E, ε4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet 3:569-574
32. Chou SM (1992) Pathology-light microscopy of amyotrophic lateral sclerosis In: Handbook of Amyotrophic Lateral Sclerosis, Smith RA (ed.), pp 133-181, Marcel Dekker: New York.
33. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein-E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261.921-923
34. Curcio CA, Kemper T (1984) Nucleus raphe dorsalis in dementia of the Alzheimer type: neurofibrillary changes and neuronal packing density. J Neuropathol Exp Neurol 43:359-368
35. D'Amato RJ, Zweig RM, Whitehouse PJ, Wenk GL, Singer HS, Mayeux R, Price DL, Snyder SH (1987) Aminergic systems in Alzheimer's disease and Parkinson's disease. Ann Neurol 22:229-236
36. Dal Canto MC, Gurney ME (1994a) The development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am J Pathol 145.1-9
37. Dal Canto MC, Gurney ME (1994b) Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am J Pathol 145:1271-1280
38. Dal Canto MC, Gurney ME (1995) Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,ZN SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS). Brain Res 676:25-40
39. Davies CA, Mann DMA, Sumpter PQ, Yates PO (1987) A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. J Neurol Sci 78:151-164
40. Davies P, Katzman R, Terry RD (1980) Reduced somato-statin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementia. Nature 288:279-280
41. De LaCoste M-C, White CL, III (1993) The role of cortical connectvity in Alzheimer's disease pathogenesis: a review and model system. Neurobiol Aging 14:1-16
42. De Souza EB, Whitehouse PJ, Kuhar MJ, Price DL, Vale WW (1986) Reciprocal changes in corticotrophin-releasing factor (CRF)-like immunoractivity and CRF receptors in cerebral cortex of Alzheimer's disease. Nature 319:593-595
43. DeKosky ST, Harbaugh RE, Schmitt FA, Bakay RAE, Chui HC, Knopman DS, Reeder TM, Shetter AG, Senter HJ, Markesbery WR, the Intraventricular Bethanecol Study Group (1992) Cortical biopsy in Alzheimer's disease: diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Ann Neurol 32:625-632
44. DeKosky ST, Scheff SW (1990) Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive seventy. Ann Neurol 27.457-463
45. Deng H-X, Hentati A, Tainer JA, Iqbal Z, Cayabyab A, Hung W-Y, Getzoff ED, Hu P, Herzfeldt B, Roos RP, Warner C, Deng G, Soriano E, Smyth C, Parge HE, Ahmed A, Roses AD, Hallewell RA, Pericak-Vance MA, Siddique T (1993) Amyotrophic lateral sclerosis and structural defects in Cu,Zn Superoxide dismutase. Science 261.1047-1051
46. Ernst RL, Hay JW (1994) The US economic and social costs of Alzheimer's disease revisited. Am J Public Health 84:1261-1264
47. Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, Hebert LE, Hennekens CH, Taylor JO (1989) Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported JAMA 262:2551-2556
48. Ferrier IN, Cross AJ, Johnson JA, Roberts GW, Crow TJ, Corsellis JAN, Lee YC, O'Shaughnessy D, Adrian TE, McGregor GP, Baracese-Hamilton AJ, Bloom SR (1983) Neuropeptides in Alzheimer type dementia. J Neurol Sci 62:159-170
49. Francis PT, Palmer AM, Sims NR, Bowen DM, Davison AN, Esiri MM, Neary D, Snowden JS, Wilcock GK (1985) Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment. N Engl J Med 313:7-11
50. Fridovich I (1986) Superoxide dismutases. Adv Enzymol Relat Areas Mol Biol 58:61-97
51. Fu Y-H, Kuhl DPA, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, Verkerk AJMH, Holden JJA, Fenwick RG, Jr., Warren ST, Oostra BA, Nelson DL (1991) Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67 1047-1058
52. Fu Y-H, Pizzuti A, Fenwick RG, Jr., King J, Rajnarayan S, Dunne PW, Dubel J, Nasser GA, Ashizawa T, de Jong P, Wieringa B, Korneluk R, Perryman MB, Epstein HF, Caskey CT (1992) An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255:1256-1258
53. Galasko D, Saitoh T, Xia Y, Thai LJ, Katzman R, Hill LR, Hansen L (1994) The apolipoprotein E allele ε4 is over-represented in patients with the Lewy body variant of Alzheimer's disease. Neurology 44:1950-1951
54. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, Guido T, Hagopian S, Johnson-Wood K, Khan K, Lee M, Leibowitz P, Lieberburg I, Little S, Masliah E, McConlogue L, Montoya-Zavala M, Mucke L, Paganini L, Penniman E, Power M, Schenk D, Seubert P, Snyder B, Soriano F, Tan H, Vitale J, Wadsworth S, Wolozin B, Zhao J (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein Nature 373:523-527
55. Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA framentation. J Cell Biol 119:493-501
56. Glenner GG, Wong CW (1984a) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120.885-890
57. Glenner GG, Wong CW (1984b) Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun 122:1131-1135
58. Goate A, Chartier-Harlin M-C, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rossor M, Owen M, Hardy J (1991) Segregation of a missense mutation in the amyloid, precursor protein gene with familial Alzheimer's disease. Nature 349:704-706
59. Goedert M, Sisodia SS, Price DL (1991) Neurofibrillary tangles and β-amyloid deposits in Alzheimer's disease. Curr Opin Neurobiol 1:441-447
60. Goedert M, Strittmatter WJ, Roses AD (1994) Risky apolipoprotein in brain. Nature 372:45-46
61. Goldgaber D, Lerman MI, McBride OW, Saffiotti U, Gajdusek DC (1987) Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science 235:877-880
62. Gomez-Isla T, West HL, Rebeck GW, Harr SD, Growdon JH, Locascio JJ, Perls TT, Lipsitz LA, Hyman BT (1996) Clinical and pathological correlates of apolipoprotein E ε4 in Alzheimer disease Ann Neurol 39:62-70
63. Gonatas NK, Stieber A, Mourelatos Z, Chen Y, Gonatas JO, Appel SH, Hays AP, Hickey WF, Hauw J-J (1992) Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis. Am J Pathol 140:731-737
64. Goto I, Tobimatsu S, Ohta M, Hosokawa S, Shibasaki H, Kuroiwa Y (1982) Dentatorubro-pallidoluysian degeneration: clinical, neuro-ophthalmologic, biochemical, and pathologic studies on autosomal dominant form. Neurology (NY) 32:1395-1399
65. Greenberg SG, Davies P (1990) A preparation of Alzheimer paired helical filaments that displays distinct τ proteins by polyacrylamide gel electrophoresis. Proc Natl Acad Sci USA 87:5827-5831
66. Grundke-lqbal I, Iqbal K, Quinlan M, Tung Y-C, Zaidi MS, Wisniewski HM (1986) Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem 261:6084-6089
67. Gu H, Zou Y-R, Rajewsky K (1993) Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell 73:1155-1164
68. Gu H, Marth JD, Orban PC, Mossman H, Rajewsky K (1994) Deletion of a DNA polymerase β gene segment in T cells using cell type-specific gene targeting. Science 265:103-106
69. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, Chen W, Zhai P, Sufit RL, Siddique T (1994) Motor neuron degeneration in mice that express a human Cu,Zn Superoxide dismutase mutation. Science 264:1772-1775
70. Gurney ME, Cuttings FB, Zhai P, Doble A, Taylor CP, Andrus PK, Hall ED (1996) Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol 39.147-157
71. Hamos JE, DeGennaro LJ, Drachmen DA (1989) Synaptic loss in Alzheimer's disease and other dementias. Neurology 39:355-361
72. Harding AE (1995) Inherited ataxias. Curr Opin Neurol 8:306-309
73. Hardy J, Cowburn R, Barton A, Reynolds G, Lofdahl E, O'Carroll A-M, Webster P, Winblad B (1987) Region-specific loss of glutamate innervation in Alzheimer's disease. Neurosci Lett 73:77-80
74. Harper PS, Rüdel R (1994) Myotonic dystrophy. In: Myology. Basic and Clinical, Engel AG, Franzini-Armstrong C (eds.), pp 1192-1219, McGraw-Hill, Inc.: New York.
75. Hedreen JC, Peyser CE, Folstein SE, Ross CA (1991) Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease. Neurosci Lett 133:257-261
76. Hendricks L, van Duijn CM, Cras P, Cruts M, Van Hul W, van Harskamp F, Warren A, Mclnnis MG, Antonarakis SE, Martin J-J, Hofman A, Van Broeckhoven C (1992) Presenile dementia and cerebal haemorrhage linked to a mutation at codon 692 of the β-amyloid precursor protein gene. Nature Genetics 1:218-221
77. Hendrie HC, Hall KS, Hui S, Unverzagt FW, Yu CE, Lahiri DK, Sahota A, Farlow M, Musick B, Class CA, Brashear A, Burdine VE, Osuntokun BO, Ogunniyi AO, Gureje O, Baiyewu O, Schellenberg GD (1995) Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans Ann Neurol 37.118-120
78. Herzog AG, Kemper TL (1980) Amygdaloid changes in aging and dementia Arch Neurol 37.625-629
79. Higgins LS, Holtzman DM, Rabin J, Mobley WC, Cordell B (1994) Transgenic mouse brain histopathology resembles early Alzheimer's disease. Ann Neurol 35:598-607
80. Hirano A, Malamud N, Kurland LT, et al (1969) A review of the pathologic findings in amyotrophic lateral sclerosis. In: Motor Neuron Diseases. Research on Amyotrophic Lateral Sclerosis and Other Disorders, Norris FH, Kurland LT (eds.), pp 51-60, Grune & Stratton: New York.
81. Hirano A, Kato S (1992) Fine structural study of sporadic and familial amyotrophic lateral sclerosis. In: Handbook of Amyotrophic Lateral Sclerosis, Smith RA (ed.), pp 183-192, Marcel Dekker: New York.
82. Rowland DS, Savage MJ, Huntress FA, Wallace RE, Schwartz DA, Loh T, Melloni RH, Jr., DeGennaro LJ, Greenberg BD, Siman R, Swanson ME, Scott RW (1995) Mutant and native human β-amyloid precursor proteins in transgenic mouse brain. Neurobiol Aging 16:685-699
83. Hsiao KK, Borchelt DR, Olson K, Johannsdottir R, Kitt C, Yunis W, Xu S, Eckman C, Younkin S, Price D, ladecola C, Clark HB, Carlson G (1995) Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 15.1203-1218
84. Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72:971-983
85. Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL (1984) Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 225:1168-1170
86. Hyman BT, Van Hoesen GW, Kromer LJ, Damasio AR (1986) Perforant pathway changes and the memory impairment of Alzheimer's disease Ann Neurol 20:472-481
87. Hyman BT, Van Hoesen GW, Damasio AR (1990) Memory-related neural systems in Alzheimer's disease: an anatomic study. Neurology 40:1721-1730
88. lizuka R, Hirayama K, Maehara K (1984) Dentato-rubropallido-luysian atrophy: a clinico-pathological study. J Neurol Neurosurg Psychiatry 47.1288-1298
89. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y (1994) Visualization of Aβ42(43)-positive and Aβ40-positive senile plaques with end-specific Aβ-monoclonal antibodies. evidence that an initially deposited Aβ species is Aβ1-42(43). Neuron 13:45-53
90. Jackson M, Gentleman S, Lennox G, Ward L, Gray T, Randall K, Morrell K, Lowe J (1995) The cortical neuritic pathology of Huntington's disease Neuropathol Appl Neurobiol 21:18-26
91. Jennings C (1995) How trinucleotide repeats may function. Nature 378:127
92. Junck L, Fink JK (1996) Machado-Joseph disease and SCA3: the genotype meets the phenotypes. Neurology 46:4-8
93. Kang J, Lemaire H-G, Unterbeck A, Salbaum JM, Masters CL, Grzeschik K-H, Multhaup G, Beyreuther K, Mu̇ller-Hill B (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor Nature 325:733-736
94. Kato S, Oda M, Hayashi H (1993) Neuropathology in amyotrophic lateral sclerosis patients on respirators, uniformity and diversity in 13 cases. Neuropathology 13:229-236
95. Katzman R (1994) Apolipoprotein E and Alzheimer's disease. Curr Opin Neurobiol 4:703-707
96. Kawaguchi Y, Okamoto T, Taniwaki M, Aizawa M, Inoue M, Katayama S, Kawakami H, Nakamura S, Nishimura M, Akiguchi I, Kimura J, Narumiya S, Kakizuka A (1994) CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nature Genetics 8:221-227
97. Kemper T (1984) Neuroanatomical and neuropathological changes in normal aging and in dementia. In: Clinical Neurology of Aging, Albert ML (ed.), pp 9-52, Oxford University Press: New York.
98. Kitaguchi N, Takahashi Y, Tokushima Y, Shiojiri S, Ito H (1988) Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature 331:530-532
99. Knight SJL, Flannery AV, Hirst MC, Campbell L, Christodoulou Z, Phelps SR, Pointon J, Middleton-Price HR, Barnicoat A, Pembrey ME, Holland J, Oostra BA, Bobrow M, Davies KE (1993) Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation. Cell 74:127-134
100. Koide R, Ikeuchi T, Onodera O, Tanaka H, Igarashi S, Endo K, Takahashi H, Kondo R, Ishikawa A, Hayashi T, Saito M, Tomoda A, Miike T, Naito H, Ikuta F, Tsuji S (1994) Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nature Genetics 6:9-13
101. Kosik KS, Orecchio LD, Binder L, Trojanowski JQ, Lee VM-Y, Lee G (1988) Epitopes that span the tau molecule are shared with paired helical filaments Neuron 1:817-825
102. Kovacs DM, Fausett HJ, Page KJ, Kim T-W, Moir RD, Merriam DE, Hollister RD, Hallmark OG, Mancini R, Felsenstein KM, Hyman BT, Tanzi RE, Wasco W (1996) Alzheimer-associated presenilins 1 and 2. neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nature Med 2:224-229
103. Kowall NW, Beal MF, Busciglio J, Duffy LK, Yankner BA (1991) An in vivo model for the neurodegenerative effects of β amyloid and protection by substance P. Proc Natl Acad Sci USA 88:7247-7251
104. Kowall NW, Beal MF (1991) Glutamate-, glutaminase-, and taurine-immunoreactive neurons develop neurofibrillary tangles in Alzheimer's disease. Ann Neurol 29:162-167
105. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352:77-79
106. LaFerla FM, Tinkle BT, Biebench CJ, Haudenschild CC, Jay G (1995) The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nature Genetics 9.21-30
107. Lamb BT, Sisodia SS, Lawler AM, Slunt HH, Kitt CA, Kearns WG, Pearson PL, Price DL, Gearhart JD (1993) introduction and expression of the 400 kilobase precursor amyloid protein gene in transgenic mice. Nature Genetics 5:22-30
108. Lassmann H, Bancher C, Breitschopf H, Wegiel J, Bobinski M, Jellinger K, Wisniewski HM (1995) Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ Acta Neuropathol 89:35-41
109. Lee VM-Y, Balin BJ, Otvos L, Jr, Trojanowski JQ (1991) A68: a major subunit of paired helical filaments and derivatized forms of normal tau. Science 251:675-678
110. Lee VM-Y (1995) Disruption of the cytoskeleton in Alzheimer's disease. Curr Opin Neurobiol 5:663-668
111. Lee VM-Y, Trojanowski JQ (1992) The disordered neuronal cytoskeleton in Alzheimer's disease. Curr Opin Neurobiol 2:653-656
112. Lehmann J, Struble RG, Antuono PG, Coyle JT, Cork LC, Price DL (1984) Regional heterogeneity of choline acetyl-transferase activity in primate neocortex. Brain Res 322:361-364
113. Levitan D, Greenwald I (1995) Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 377-351-354
114. Levy E, Carman MD, Fernandez-Madrid IJ, Power MD, Lieberburg I, van Duinen SG, Bots GTAM, Luyendijk W, Frangione B (1990) Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrage, Dutch type. Science 248:1124-1126
115. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, Yu C-E, Jondro PD, Schmidt SD, Wang K, Crowley AC, Fu Y-H, Guenette SY, Galas D, Nemens E, Wijsman EM, Bird TD, Schellenberg GD, Tanzi RE (1995a) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269:973-977
116. Levy-Lahad E, Wijsman EM, Nemens E. Anderson L, Goddard KAB, Weber JL, Bird TD, Schellenberg GD (1995b) A familial Alzheimer's disease locus on chromosome 1. Science 269:970-973
117. Li J, Ma J, Potter H (1995) Identification and expression analysis of a potential familial Alzheimer disease gene on chromosome 1 related to AD3. Proc Natl Acad Sci USA 92:12180-12184
118. Li S-H, Mclnnis MG, Margolis RL, Antonarakis SE, Ross CA (1993) Novel triplet repeat containing genes in human brain: cloning, expression, and length polymorphisms. Genomics 16:572-579
119. Li X-J, Li S-H, Sharp AH, Nucifora FC, Jr., Schilling G, Lanahan A, Worley P, Snyder SH, Ross CA (1995) A huntington-associated protein enriched in brain with implications for pathology. Nature 378:398-402
120. Liu XF, Cizewski Culotta V (1994) The requirement for yeast superoxide dismutase is bypassed through mutations in BSD2, a novel metal homeostasis gene. Mol Cell Biol 14.7037-7045
121. Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, Jansen G, Neville C, Narang M, Barceló J, O'Hoy K, Leblond S, Earle-Macdonald J, de Jong PJ, Wieringa B, Korneluk RB (1992) Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science 255:1253-1255
122. Mahley RW (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240:622-630
123. Mann DMA, Marcyniuk B, Yates PO, Neary D, Snowden JS (1988) The progression of the pathological changes of Alzheimer's disease in frontal and temporal neocortex examined both at biopsy and at autopsy. Neuropathol Appl Neurobiol 14:177-195
124. Masliah E, Terry RD, DeTeresa RM, Hansen LA (1989) Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease. Neurosci Lett 103:234-239
125. Masliah E, Terry RD, Alford M, DeTeresa R (1990) Quantitative immunohistochemistry of synaptophysin in human neocortex: an alternative method to estimate density of presynaptic terminals in paraffin sections. J Histochem Cytochem 38 837-844
126. Masliah E, Hansen L, Albnght T, Mallory M, Terry RD (1991) Immunoelectron microscopic study of synaptic pathology in Alzheimer's disease. Acta Neuropathol 81.428-433
127. Masliah E, Ellisman M, Carragher B, Mallory M, Young S, Hansen L, DeTeresa R, Terry RD (1992) Three-dimensional analysis of the relationship between synaptic pathology and neuropil threads in Alzheimer disease. J Neuropathol Exp Neurol 51.404-414
128. Masters CL, Multhaup G, Simms G, Pottgiesser J, Martins RN, Beyreuther K (1985a) Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels EMBO J 4:2757-2763
129. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985b) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 82:4245-4249
130. Matsumoto S, Kusaka H, Murakami N, Hashizume Y, Okazaki H, Hirano A (1992) Basophilic inclusions in sporadic juvenile amyotrophic lateral sclerosis: an immunocytochemical and ultrastructural study. Acta Neuropathol 83:579-583
131. Mayeux R, Stern Y, Ottman R, Tatemichi TK, Tang M-X, Maestre G, Ngai C, Tycko B, Ginsberg H (1993) The apolipoprotein ∈4 allele in patients with Alzheimer's disease. Ann Neurol 34.752-754
132. Moran PM, Higgins LS, Cordell B, Moser PC (1995) Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human β-amyloid precursor protein. Proc Natl Acad Sci USA 92:5341-5345
133. Mourelatos Z, Gonatas NK, Stieber A, Gurney ME, Dal Canto MC (1996) The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu,Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease. Proc Natl Acad Sci USA 93:5472-5477
134. Mullan M, Crawford F, Axelman K, Houlden H, Lillius L, Winblad B, Lannfelt L (1992) A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nature Genetics 1:345-347
135. Nagafuchi S, Yanagisawa H, Sato K, Shirayama T, Ohsaki E, Bundo M, Takeda T, Tadokoro K, Kondo I, Murayama N, Tanaka Y, Kikushima H, Umino K, Kurosawa H, Furukawa T, Nihei K, Inoue T, Sano A, Komure O, Takahashi M, Yoshizawa T, Kanazawa I, Yamada M (1994) Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. Nature Genetics 6:14-18
136. Naito H, Oyanagi S (1982) Familial myoclonus epilepsy and choreoathetosis: hereditary dentatorubral-pallidoluysian atrophy Neurology (NY) 32:798-807
137. Nalbantoglu J, Gilfix BM, Bertrand P, Robitaille Y, Gauthier S, Rosenblatt DS, Poirier J (1994) Predictive value of apolipoprotein E genotyping in Alzheimer's disease. results of an autopsy series and an analysis of several combined studies. Ann Neurol 36:889-895
138. Naruse S, Igarashi S, Kobayashi H, Aoki K, Inuzuka T, Kaneko K, Shimizu T, Iihara K, Kojima T, Miyatake T, Tsuji S (1991) Mis-sense mutation Val->lle in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease. Lancet 337:978-979
139. Oppenheimer DR, Esin MM (1992) Diseases of the basal ganglia, cerebellum and motor neurons. In: Greenfield's Neuropathology, Adams JH, Duchen LW (eds.), pp 988-1045. Oxford University Press: New York
140. Ordovas JM, Litwack-Klein L, Wilson PWF, Schaefer MM, Schaefer EJ (1987) Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms. J Lipid Res 28:371-380
141. Orr HT, Chung M-Y, Banfi S, Kwiatkowski TJ, Jr., Servadio A, Beaudet AL, McCall AE, Duvick LA, Ranum LPW, Zoghbi HY (1993) Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nature Genetics 4:221-226
142. Palmiter RD, Brinster RL (1986) Germ-line transformation of mice. Annu Rev Genet 20:465-499
143. Pardo CA, Xu Z, Borchelt DR, Price DL, Sisodia SS, Cleveland DW (1995) Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. Proc Natl Acad Sci USA 92:954-958
144. Parrish JE, Oostra BA, Verkerk AJMH, Richards CS, Reynolds J, Spikes AS, Shaffer LG, Nelson DL (1994) Isolation of a GCC repeat showing expansion in FRAXF, a fragile site distal to FRAXA and FRAXE. Nature Genetics 8:229-235
145. Perdahl E, Adolfsson R, Alafuzoff I, Albert KA, Nestler EJ, Greengard P, Winblad B (1984) Synapsin I (Protein I) in different brain regions in senile dementia of Alzheimer type and in multiinfarct dementia. J Neural Transm 60:133-141
146. Perry EK (1986) The cholinergic hypothesis - ten years on. Br Med Bull 42:63-69
147. Perry RH, Candy JM, Perry EK, Irving D, Blessed G, Fairbairn AF, Tomlinson BE (1982) Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease. Neurosci Lett 33:311-315
148. Pfeiffer RF, McComb RD (1990) Dentatorubro-pallidoluysian atrophy of the myoclonus epilepsy type with posterior column degeneration. Mov Disord 5:134-138
149. Pike CJ, Walencewicz AJ, Glabe CG, Cotman CW (1991) Aggregation- related toxicity of synthetic β-amyloid protein in hippocampal cultures, Eur J Pharmacol 207.367-368
150. Poirier J, Davignon J, Bouthillier D, et al. (1993) Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342:697-699
151. Ponte P, Gonzalez-DeWhitt P, Schilling J, Miller J, Hsu D, Greenberg B, Davis K, Wallace W, Lieberburg I, Fuller F, Cordell B (1988) A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature 331:525-532
152. Porter JA, von Kessler DP, Ekker SC, Young KE, Lee JJ, Moses K, Beachy PA (1995) The product of hedgehog autoproteolytic cleavage active in local and long-range signalling. Nature 374:363-366
153. Portera-Cailliau C, Hedreen JC, Price DL, Koliatsos VE (1995) Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models J Neurosci 15:3775-3787
154. Price DL, Borchelt DR, Walker LC, Sisodia SS (1992) Toxicity of synthetic Aβ peptides and modeling of Alzheimer's disease. Neurobiol Aging 13:623-625
155. Price DL, Sisodia SS (1994) Cellular and molecular biology of Alzheimer's disease and animal models Annu Rev Med 45:435-446
156. Probst A, Langui D, Ipsen S, Robakis N, Ulrich J (1991) Deposition of β/A4 protein along neuronal plasma membranes in diffuse senile plaques Acta Neuropathol 83:21-29
157. Rabizadeh S, Butler Gralla E, Borchelt DR, Gwinn R, Selverstone Valentine J, Sisodia S, Wong P, Lee M, Hahn H, Bredesen DE (1995) Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene, studies in yeast and neural cells. Proc Natl Acad Sci USA 92:3024-3028
158. Reaume AG, Elliott JL, Hoffman EK, Kowall NW, Ferrante RJ, Siwek DF, Wilcox HM, Flood DG, Beal MF, Brown RH, Jr., Scott RW, Snider WD (1996) Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nature Genetics
159. Rebeck GW, Reiter JS, Strickland DK, Hyman BT (1993) Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions Neuron 11:575-580
160. Ripps ME, Huntley GW, Hof PR, Morrison JH, Gordon JW (1995) Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 92:689-693
161. Robakis NK, Ramakrishna N, Wolfe G, Wisniewski HM (1987a) Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides. Proc Natl Acad Sci USA 84:4190-4194
162. Robakis NK, Wisniewski HM, Jenkins EC, Devine-Gage EA, Houck GE, Yau X-L, Ramakrishna N, Wolfe G, Silverman WP, Brown WT (1987b) Chromosome 21q21 sublocalisation of gene encoding beta-amyloid peptide in cerebral vessels and neuritic (senile) plaques of people with Alzheimer disease and Down syndrome. Lancet 1 384-385
163. Rogaev El, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, Chi H, Lin C, Holman K, Tsuda T, Mar L, Sorbi S, Nacmias B, Piacentini S, Amaducci L, Chumakov I, Cohen D, Lannfelt L, Fraser PE, Rommens JM, St George-Hyslop PH (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376:775-778
164. Roher A, Wolfe D, Palutke M, KuKurga D (1986) Purification, ultrastructure, and chemical analysis of Alzheimer disease amyloid plaque core protein. Proc Natl Acad Sci USA 83:2662-2666
165. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng H-X, Rahmani Z, Krizus A, McKenna-Yasek D, Cayabyab A, Gaston SM, Berger R, Tanzi RE, Halperin JJ, Herzfeldt B, Van den Bergh R, Hung W-Y, Bird T, Deng G, Mulder DW, Smyth C, Laing NG, Soriano E, Pericak-Vance MA, Haines J, Rouleau GA, Gusella JS, Horvitz HR, Brown RH, Jr. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59-62
166. Roses AD (1994) Apolipoprotein E affects the rate of Alzheimer disease expression: β-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J Neuropathol Exp Neurol 53:429-437
167. Roses AD, Strittmatter WJ, Pericak-Vance MA, Corder EH, Saunders AM, Schmechel DE (1994) Clinical application of apolipoprotein E genotyping to Alzheimer's disease Lancet 343 1564-1565
168. Roses AD (1995) Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease. Ann Neurol 38 6-14
169. Ross CA, Mclnnis MG, Margolis RL, Li S-H (1993) Genes with triplet repeats: candidate mediators of neuropsychiatric disorders. Trends Neurosci 16:254-260
170. Rossor MN, Emson PC, Mountjoy CQ, Roth M, Iversen LL (1980) Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type. Neurosci Lett 20:373-377
171. Rouleau GA, Clark AW, Rooke K, Pramatarova A, Krizus A, Suchowersky O, Julien J-P, Figlewicz D (1996) SOD1 mutation is associated with accumulation of neurofila-ments in amyotrophic lateral sclerosis. Ann Neurol 39:128-131
172. Saunders AM, Strittmatter WJ, Schmechel D, St.George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD (1993) Association of apolipoprotein E allele ∈A with late-onset familial and sporadic Alzheimer's disease. Neurology 43:1467-1472
173. Schedl A, Montoliu L, Kelsey G, Schütz G (1993) A yeast artificial chromosome covering the tyrosinase gene confers copy number-dependent expression in transgenic mice. Nature 362:258-261
174. Scheff SW, Price DA (1993) Synapse loss in the temporal lobe in Alzheimer's disease. Ann Neurol 33:190-199
175. Schellenberg GD (1995) Progress in Alzheimer's disease genetics. Curr Opin Neurol 8:262-267
176. Scott MR, Köhler R, Foster D, Prusiner SB (1992) Chimeric prion protein expression in cultured cells and transgenic mice. Protein Sci 1:986-997
177. Scott SA, DeKosky ST, Sparks DL, Knox CA, Scheff SW (1992) Amygdala cell loss and atrophy in Alzheimer's disease. Ann Neurol 32:555-563
178. Selkoe DJ, Bell DS, Podlisny MB, Price DL, Cork LC (1987) Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease. Science 235:873-877
179. Selkoe DJ (1995) Missense on the membrane. Nature 375:734-735
180. Sharp AH, Ross CA (1996) Neurobiology of Huntington's disease. Neurobiol Dis 3:3-15
181. Sherrington R, Rogaev El, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin J-F, Bruni AC, Montesi MP, Sorbi S, Rainero I, Pinessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinsky RJ, Wasco W, Da Silva HAR, Haines JL, Pericak-Vance MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM, St George-Hyslop PH (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375:754-760
182. Shibata N, Hirano M, Kobayashi K (1993) Immunohistochemical demonstration of Cu/Zn superoxide dismutase in the spinal cord of patients with familial amyotrophic lateral sclerosis. Acta Histochem Cytochem 26:619-622
183. Shibata N, Hirano A, Kobayashi M, Siddique T. Deng H-X, Hung W-Y, Kato T, Asayama K (1996) Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J Neuropathol Exp Neurol 55:481-490
184. Siddique T, Figlewicz DA, Pericak-Vance MA, Haines JL, Rouleau G, Jeffers AJ, Sapp P, Hung W-Y, Bebout J, McKenna-Yasek D, Deng G, Horvitz HB, Gusella JF, Brown RH, Jr, Roses AD, Roos RP, Williams DB, Mulder DW, Watkins PC, Noore R, Nicholson G, Reed R, Brooks BR, Festoff B, Antel JP, Tandan R, Munsat TL, Laing NG, Halperin JJ, Norris FH, Van den Bergh R. Swerts L, Tanzi RE, Jubelt B, Mathews KD, Bosch EP (1991) Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity. N Engl J Med 324:1381-1384
185. Slunt HH, Thinakaran G, von Koch C, Lo ACY, Tanzi RE, Sisodia SS (1994) Expression of a ubiquitous, cross-reactive homologue of the mouse β-amyloid precursor protein (APP). J Biol Chem 269:2637-2644
186. Slunt HH, Thinakaran G, Lee MK, Sisodia SS (1995) Nucleotide sequence of the chromosome 14-encoded S182 cDNA and revised secondary structure prediction. Amyloid: Int J Exp Clin Invest 2:188-190
187. Smale G, Nichols NR, Brady DR, Finch CE, Horton WE, Jr. (1995) Evidence for apoptotic cell death in Alzheimer's disease. Exp Neurol 133.225-230
188. Smith JK, Gonda VE, Malamud N (1958) Unusual form of cerebellar ataxia. Combined dentato-rubral and pallido-Luysian degeneration. Neurology 8:205-209
189. St George-Hyslop PH, Haines P, Rogaev E, Mortilla M, Vaula G, Pericak-Vance M, Foncin J-F, Montesi M, Bruni A, Sorbi S, Rainero I, Pinessi L, Pollen D, Polinsky R, Nee L, Kennedy J, Macciardi F, Rogaeva E, Liang Y, Alexandrova N, Lukiw W, Schlumpf K, Tanzi R, Tsuda T, Farrer L, Cantu J-M, Duara R, Amaducci L, Bergamini L, Gusella J, Roses A, Crapper McLachlan D (1992) Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nature Genetics 2:330-334
190. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90:1977-1981
191. Struble RG, Lehmann J, Mitchell SJ, McKinney M, Price DL, Coyle JT, DeLong MR (1986) Basal forebrain neurons provide major cholinergic innervation of primate neocortex. Neurosci Lett 66:215-220
192. Su JH, Anderson AJ, Cummings BJ, Cotman CW (1994) Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport 5:2529-2533
193. Takahashi H, Ohama E, Naito H, Takeda S, Nakashima S, Makifuchi T, Ikuta F (1988) Hereditary dentatorubral-pallidoluysian atrophy: clinical and pathologic variants in a family. Neurology 38:1065-1070
194. Takahashi JS, Pinto LH, Hotz Vitaterna M (1994) Forward and reverse genetic approaches to behavior in the mouse. Science 264:1724-1733
195. Tanzi RE, McClatchey Al, Lampert ED, Villa-Komaroff L, Gusella JF, Neve RL (1988) Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature 331:528-530
196. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572-580
197. Thinakaran G, Borchelt DR, Lee MK, Slunt HH, Spitzer L, Kim G, Ratovitski T, Davenport F, Nordstedt C, Seeger M, Hardy J, Levey Al, Gandy SE, Jenkins N, Copeland N, Price DL, Sisodia SS (1996a) Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo Neuron 17:181-190
198. Thinakaran G, Teplow DB, Siman R, Greenberg B, Sisodia SS (1996b) Metabolism of the "Swedish" APP variant in Neuro2A (N2a) cells. evidence that cleavage at the "β-secretase" site occurs in the Golgi apparatus J Biol Chem 271:9390-9397
199. Tomlinson BE, Irving D, Blessed G (1981) Cell loss in locus ceruleus in senile dementia of Alzheimer type. J Neurol Sci 49:419-428
200. Trottier Y, Lutz Y Stevanin G, Imbert G, Devys D, Cancel G, Saudou F, Weber C, David G, Tora L, Agid Y, Brice A, Mandel JL (1995) Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias Nature 378:403-406
201. Tsai M-S, Tangalos EG, Petersen RC, Smith GE, Schaid DJ, Kokmen E, Ivnik RJ, Thibodeau SN (1994) Apolipoprotein E: risk factor for Alzheimer disease. Am J Hum Genet 54:643-649
202. Tu P-H, Raju P, Robinson KA, Gurney ME, Trojanowski JQ, Lee VM-Y (1996) Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc Natl Acad Sci USA 93:3155-3160
203. Van Broeckhoven C, Haan J, Bakker E, Hardy JA, Van Hul W, Wehnert A, Vegter-Van der Vlis M, Roos RAC (1990) Amyloid β protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). Science 248:1120-1122
204. van Duijn CM, de Knijff P, Wehnert A, De Voecht J, Bronzova JB, Havekes LM, Hofman A, Van Broeckhoven C (1995) The apolipoprotein E ∈2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. Ann Neurol 37:605-610
205. Vogels OJM, Broere CAJ, Ter Laak HJ, Ten Donkelaar HJ, Nieuwenhuys R, Schultz BPM (1990) Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease. Neurobiol Aging 11:3-13
206. Vonsattel J-P, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP, Jr. (1985) Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 44:559-577
207. Warner TT, Lennox GG, Janota I, Harding AE (1994) Autosomal-dominant Dentatorubropallidoluysian atrophy in the United Kingdom. Mov Disord 9:289-296
208. Warren ST (1996) The expanding world of trinucleotide repeats. Science 271.1374-1375
209. Wasco W, Gurubhagavatula S, Paradis Md, Romano DM, Sisodia SS, Hyman BT, Neve RL, Tanzi RE (1993) Isolation and characterization of APLP2 encoding a homologue of the Alzheimer's associated amyloid β protein precursor. Nature Genetics 5:95-99
210. Weisgraber KH, Pitas RE, Mahley RW (1994) Lipoproteins, neurobiology, and Alzheimer's disease: structure and function of apolipoprotein E. Curr Opin Struct Biol 4:507-515
211. West MJ, Coleman PD, Flood DG, Troncoso JC (1994) Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 344:769-772
212. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, DeLong MR (1982) Alzheimer's disease and senile dementia loss of neurons in the basal forebrain. Science 215:1237-1239
213. Whitehouse PJ, Martino AM, Antuono PG, Lowenstein PR, Coyle JT, Price DL, Kellar KJ (1986) Nicotinic acetylcholine binding sites in Alzheimer's disease. Brain Res 371:146-151
214. Wiedau-Pazos M, Goto JJ, Rabizadeh S, Gralla EB, Roe JA, Lee MK, Valentine JS, Bredesen DE (1996) Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis Science 271 515-518
215. Wolozin BL, Pruchnicki A, Dickson DW, Davies P (1986) A neuronal antigen in the brains of Alzheimer patients. Science 232:648-650
216. Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, Jenkins NA, Sisodia SS, Cleveland DW, Price DL (1995) An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14:1105-1116
217. Yankner BA, Dawes LR, Fisher S, Villa-Komaroff L, Oster-Granite ML, Neve RL (1989) Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 245.417-420
218. Yankner BA (1996) Mechanisms of neuronal degeneration in Alzheimer's disease Neuron 16:921-932
219. Yoshikawa K, Aizawa T, Hayashi Y (1992) Degeneration in vitro of post-mitotic neurons overexpressing the Alzheimer amyloid protein precursor. Nature 359:64-67
220. Zweig RM, Ross CA, Hedreen JC, Steele C, Cardillo JE, Whitehouse PJ, Folstein MF, Price DL (1988) The neuropathology of aminergic nuclei in Alzheimer's disease. Ann Neurol 24:233-242